Is HQL research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HQL. It does not provide personalized investment advice.

HQL (abrdn Life Sciences Investors) Stock Analysis - Financials

abrdn Life Sciences Investors (HQL) is a publicly traded Financial Services sector company. As of July 21, 2026, HQL trades at $19.75 with a market cap of $600.25M and a P/E ratio of 0.00. HQL moved +1.00% today. Year to date, HQL is +16.10%; over the trailing twelve months it is +44.74%. Its 52-week range spans $10.55 to $21.32. Rallies surfaces HQL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are HQL's key financials?

HQL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HQL recently traded at $19.75. Market cap is $600.25M. P/E ratio is 0.00. Revenue is $0.

HQL Key Metrics

Key financial metrics for HQL
Metric	Value
Price	$19.75
Market Cap	$600.25M
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	0.56%
52-Week High	$21.32
52-Week Low	$10.55
Volume	52.72K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

HQL Analyst Consensus

HQL analyst coverage data. Average price target: $0.00.

Common questions about HQL

What are HQL's key financials?: HQL financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. HQL recently traded at $19.75. Market cap is $600.25M. P/E ratio is 0.00. Revenue is $0.
Is HQL research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HQL. It does not provide personalized investment advice.